🔎 Trials Near Me

Home › Scleroderma › North Carolina › Charlotte

Scleroderma clinical trials in Charlotte, NC

3 studies for Scleroderma are looking for participants at sites in and around Charlotte (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

RecruitingPhase 1
  • Atrium Health Rheumatology-Southpark, Charlotte
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

RecruitingPhase 1/2
  • Nkarta Investigational Site, Charlotte
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

RecruitingPhase 2
  • Artiva Investigational Site Charlotte, Charlotte
  • Artiva Investigational Site Charlotte, Charlotte
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114

About Scleroderma

Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.

More about Scleroderma on MedlinePlus

Scleroderma trials in other cities

Other studies in Charlotte

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.